[HTML][HTML] Ruthenium complexes as promising candidates against lung cancer

Q Sun, Y Li, H Shi, Y Wang, J Zhang, Q Zhang - Molecules, 2021 - mdpi.com
Lung cancer is one of the most common malignancies with the highest mortality rate and the
second-highest incidence rate after breast cancer, posing a serious threat to human health …

Recent advances of gold compounds in anticancer immunity

S Yue, M Luo, H Liu, S Wei - Frontiers in Chemistry, 2020 - frontiersin.org
In recent years, gold compounds have gained more and more attentions in the design of
new metal anticancer drugs. Numerous researches have reported that gold compounds, in …

Construction of monophosphine–metal complexes in privileged diphosphine-based covalent organic frameworks for catalytic asymmetric hydrogenation

Z Zheng, C Yuan, M Sun, J Dong, Y Liu… - Journal of the American …, 2023 - ACS Publications
Privileged diphosphine ligands that chelate many transition metals to form stable chelation
complexes are essential in a variety of catalytic processes. However, the exact identity of the …

[HTML][HTML] Research progress on the biological activities of metal complexes bearing polycyclic aromatic hydrazones

R Liu, J Cui, T Ding, Y Liu, H Liang - Molecules, 2022 - mdpi.com
Due to the abundant and promising biological activities of aromatic hydrazones, it is of great
significance to study the biological activities of their metal complexes for the research and …

Metal complexes as promising matrix metalloproteinases regulators

YT Nguyen, N Kim, HJ Lee - International Journal of Molecular Sciences, 2023 - mdpi.com
Nowadays, cancers and dementia, such as Alzheimer's disease, are the most fatal causes of
death. Many studies tried to understand the pathogenesis of those diseases clearly and …

Recent advancements in organotin (IV) complexes as potential anticancer agents

J Devi, J Yadav - Anti-Cancer Agents in Medicinal Chemistry …, 2018 - ingentaconnect.com
Cancer is a multistep disease incorporating physical, chemical, environmental, metabolic
and genetic factors, which play direct or indirect role in the induction and deterioration of …

Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors

P Thangavel, B Viswanath, S Kim - International journal of …, 2017 - Taylor & Francis
In recent years, the field of metal-based drugs has been dominated by other existing
precious metal drugs, and many researchers have focused their attention on the synthesis of …

New binuclear Ni (II) metallates containing ONS chelators: synthesis, characterisation, DNA binding, DNA cleavage, protein binding, antioxidant activity, antimicrobial …

G Kalaiarasi, R Jain, H Puschman… - New Journal of …, 2017 - pubs.rsc.org
Four new complexes with bridged bis (diphenylphosphino) ethane containing 3-methoxy
salicylaldehyde 4 (N)-substituted thiosemicarbazone were prepared and characterised by …

Organoruthenium metallocycle induced mutation in gld-1 tumor suppression gene in JK1466 strain and appreciable lifespan expansion

S Nandhini, M Ranjani, G Thiruppathi… - Journal of Inorganic …, 2024 - Elsevier
Abstract Four Ru (II) complexes (A2-A5) were synthesized from the reaction of coumarin
Schiff base ligands (7da2-tsc, 7da3-mtsc, 7da4-etsc and 7da5-ptsc) with [RuHCl (CO)(PPh …

Synthesis of Ru (II) cyclometallated complexes via C (aryl)–S bond activation: X-ray structure, DNA/BSA protein binding and antiproliferative activity

A Das, S Mandal, R Mukherjee, R Naskar… - New Journal of …, 2023 - pubs.rsc.org
As a contribution to the development of new ruthenium complexes with pharmacologically
interesting properties, two new cyclometallated ruthenium (II) carbonyl complexes of the …